Cited by 203Hypothalamic control of reproductive hormonesGenetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesSexual Differentiation and Disorders

The DOI matches its Crossref record.

Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome

Hardelin, Jean-Pierre, Levilliers, Jacqueline, Blanchard, Stéphane, Carel, Jean-Claude, Leutenegger, Marc, Pinard-Bertelletto, Jean-Pierre, Bouloux, Pierre, Petit, Christine·1993·Human Molecular Genetics

DOI 10.1093/hmg/2.4.373

Open this paper in CoChat — free account

Abstract

Kallmann syndrome represents the association of hypogonadotropic hypogonadism with anosmia. Three modes of transmission, X chromosome-linked, autosomal recessive and autosomal dominant, have been described. The KAL gene, responsible for the X-linked form of the disease, has been isolated and its intron-exon organization recently determined. We have searched for mutations of the KAL gene in 21 unrelated males affected by familial Kallmann syndrome. In these families, segregation of the disease was suggestive of the X-linked mode of transmission. In 2 families, large Xp22.3 deletions, both including the entire KAL gene, have been detected by Southern blot analysis. Here we report the sequence analysis of the entire coding region of the KAL gene in the 19 remaining patients. The approach consisted of sequencing each of the 14 coding exons and splice site junctions. Each exon was amplified by PCR on the genomic DNA, using oligonucleotides from the flanking intronic sequences as specific primers. Nine point mutations were identified at separate locations in four exons and one splice site, providing strong evidence for heterogeneity in mutations responsible for the X-linked Kallmann syndrome. In addition, the high frequency of unilateral renal aplasia in X-linked Kallmann patients (6 out of 11 males with identified alterations of the KAL gene) should be emphasized.

Integrity signals

Registry

Crossref · 10.1093/hmg/2.4.373

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment
Boehm, U., Bouloux, P.-M., Dattani, M. T., de Roux, N., Dodé, C., Dunkel, L., Dwyer, A. A., Giacobini, P., Hardelin, J.-P., Juul, A., et al. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.112 · Cited by 874
Self-citation
Glycans and neural cell interactions
KLEENE, R. B., & Schachner, M. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1349 · Cited by 522
“( Box 1 ), and a mutation of this motif in the Kallmann's syndrome protein anosmin leads to olfactory defect”
Background
Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing
Jiang, Y.-H., Yuen, R. K. C., Jin, X., Wang, M., Chen, N., Wu, X., Ju, J., Mei, J., Shi, Y., He, M., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.06.012 · Cited by 474
“We evaluated the approach by using the validation results of (1) all genomic de novo SNVs in one family (2-1266) and (2) Sanger”
Method
Kallmann Syndrome: Mutations in the Genes Encoding Prokineticin-2 and Prokineticin Receptor-2
Dodé, C., Teixeira, L., Levilliers, J., Fouveaut, C., Bouchard, P., Kottler, M.-L., Lespinasse, J., Lienhardt-Roussie, A., Mathieu, M., Moerman, A., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020175 · Cited by 457
“The primers used for the KAL1 and FGFR1 coding exons have been reported [9,10].”
MethodSelf-citation
Gonadotropin-Releasing Hormone Deficiency in the Human (Idiopathic Hypogonadotropic Hypogonadism and Kallmann's Syndrome): Pathophysiological and Genetic Considerations
Seminara, S. B., Hayes, F. J., & Crowley, W. F. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0344 · Cited by 419
Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism
Pitteloud, N., Quinton, R., Pearce, S., Raivio, T., Acierno, J., Dwyer, A., Plummer, L., Hughes, V., Seminara, S., Cheng, Y.-Z., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29884 · Cited by 379
Self-citation
The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism
Bianco, S. D. C., & Kaiser, U. B. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.177 · Cited by 336
Point Mutations and an Intragenic Deletion in LIS1, the Lissencephaly Causative Gene in Isolated Lissencephaly Sequence and Miller-Dieker Syndrome
Nigro, C. L., Chong, S. S., Smith, A. C. M., Dobyns, W. B., Carrozzo, R., & Ledbetter, D. H. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.157 · Cited by 321
“neural-cell adhesion molecules, as well as with other molecules involved in neuronal migration and axonal pathfinding (25,26).”
Background
Delayed Puberty and Hypogonadism Caused by Mutations in the Follicle-Stimulating Hormone β-Subunit Gene
Layman, L. C., Lee, E. J., Peak, D. B., Namnoum, A. B., Vu, K. V., van Lingen, B. L., Gray, M. R., McDonough, P. G., Reindollar, R. H., & Jameson, J. L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370905 · Cited by 269
Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism
Miraoui, H., Dwyer, A. A., Sykiotis, G. P., Plummer, L., Chung, W., Feng, B., Beenken, A., Clarke, J., Pers, T. H., Dworzynski, P., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.008 · Cited by 267
Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism
Pitteloud, N., Zhang, C., Pignatelli, D., Li, J.-D., Raivio, T., Cole, L. W., Plummer, L., Jacobson-Dickman, E. E., Mellon, P. L., Zhou, Q.-Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707173104 · Cited by 264
Male Hypogonadism Due to a Mutation in the Gene for the β-Subunit of Follicle-Stimulating Hormone
Phillip, M., Arbelle, J. E., Segev, Y., & Parvari, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382404 · Cited by 252
Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization*
Quinton, R., Duke, V. M., Robertson, A., Kirk, J. M. W., Matfin, G., de Zoysa, P. A., Azcona, C., MacColl, G., Jacobs, H. S., Conway, G. S., et al. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01277.x · Cited by 230
“Details of some of the patients have been presented in previous publications (Hardelin et al., 1992, 1993a, 1993b; Kirk et al., 1994; Quinton et al., 1996a, 1996b, 1997, 1999b; Krams et al., 1997, 1999; Mayston et al., 1997; Duke et al., 1998).”
BackgroundResultSelf-citation
Kallmann syndrome
Dodé, C., & Hardelin, J. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.206 · Cited by 232
Self-citation
Clinical Assessment and Mutation Analysis of Kallmann Syndrome 1 (KAL1) and Fibroblast Growth Factor Receptor 1 (FGFR1, orKAL2) in Five Families and 18 Sporadic Patients
Sato, N. S., Katsumata, N., Kagami, M., Hasegawa, T., Hori, N., KAWAKITA, S., Minowada, S., Shimotsuka, A., Shishiba, Y., Yokozawa, M., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030476 · Cited by 216
“The primer sequences, annealing temperatures, and PCR product sizes for KAL1 are as reported (14), and those for FGFR1 are shown in Table 2.”
BackgroundMethodResultInfluential
SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome
Hanchate, N. K., Giacobini, P., Lhuillier, P., Parkash, J., Espy, C., Fouveaut, C., Leroy, C., Baron, S., Campagne, C., Vanacker, C., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002896 · Cited by 217
“Barely 30% of the KS patients have mutations in any of the eight genes known so far, specifically, KAL1 (ID 3730) [5–7], FGFR1 (ID 2260) [8], FGF8 (ID 2253) [9], PROKR2 (ID 128674), PROK2 (ID 60675) [10], WDR11 (ID 55717) [11], HS6ST1 (ID 9394) [12], CHD7 (ID 55636) [13,14], and current efforts thus concentrate on the…”
BackgroundSelf-citation
Mutations in Prokineticin 2 and Prokineticin receptor 2 genes in Human Gonadotrophin-Releasing Hormone Deficiency: Molecular Genetics and Clinical Spectrum
Cole, L. W., Sidis, Y., Zhang, C., Quinton, R., Plummer, L., Pignatelli, D., Hughes, V. A., Dwyer, A. A., Raivio, T., Hayes, F. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2654 · Cited by 208
Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes
Pitteloud, N., Meysing, A., Quinton, R., Acierno, J. S., Dwyer, A. A., Plummer, L., Fliers, E., Boepple, P., Hayes, F., Seminara, S., et al. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.021 · Cited by 198
“Both neurologic defects (synkinesia and hearing loss) and non-neurologic defects (renal aplasia, high arched palate, labial or palatine cleft and dental agenesis) occur with variable frequency in KS ( Hardelin et al., 1993; Quinton et al., 2001).”
BackgroundSelf-citation
The Importance of Autosomal Genes in Kallmann Syndrome: Genotype-Phenotype Correlations and Neuroendocrine Characteristics
Oliveira, L. M. B., Seminara, S. B., Beranova, M., Hayes, F. J., Valkenburgh, S. B., Schipani, E., Costa, E. M. F., Latronico, A. C., Crowley, W. F., & Vallejo, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7420 · Cited by 210
The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis.
Quinton, R., Duke, V. M., de Zoysa, P. A., Platts, A., Valentine, A. R., Kendall, B. E., Pickman, S., Kirk, J. M. W., BESSER, G. M., Jacobs, H. S., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768867 · Cited by 181
Self-citation
The Complex Genetics of Kallmann Syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
Hardelin, J., & Dodé, C. (2008) · Sexual Development · doi:10.1159/000152034 · Cited by 174
“For instance, unilateral renal agenesis occurs in approximately 30% of KAL1 patients [Hardelin et al., 1993a; Kirk et al., 1994], but has not been reported in patients with FGFR1, FGF8, PROKR2 or PROK2 mutations so far.”
BackgroundInfluentialSelf-citation
Complete disruption of autism-susceptibility genes by gene editing predominantly reduces functional connectivity of isogenic human neurons
Deneault, E., White, S. H., Rodrigues, D. C., Ross, P. J., Faheem, M., Zaslavsky, K., Wang, Z., Alexandrova, R., Pellecchia, G., Wei, W., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.003 · Cited by 145
Human gene mutations causing infertility
Layman, L. C. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.153 · Cited by 164
Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1
Bülow, H. E., Berry, K. L., Haklai-Topper, L., Peles, E., & Hobert, O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092128099 · Cited by 164
Reversible Kallmann Syndrome, Delayed Puberty, and Isolated Anosmia Occurring in a Single Family with a Mutation in the Fibroblast Growth Factor Receptor 1 Gene
Pitteloud, N., Acierno, J. S., Meysing, A. U., Dwyer, A. A., Hayes, F. J., & Crowley, W. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1361 · Cited by 160
Mirror movements in X-linked Kallmann's syndrome. I. A neurophysiological study
Mayston, M. J. (1997) · Brain · doi:10.1093/brain/120.7.1199 · Cited by 152
Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1(KAL2): MUTATIONS IN BRIEF
Albuisson, J., Pêcheux, C., Carel, J.-C., Lacombe, D., Leheup, B., Lapuzina, P., Bouchard, P., Legius, E., Matthijs, G., Wasniewska, M., et al. (2005) · Human Mutation · doi:10.1002/humu.9298 · Cited by 146
“The 14 exons of the KAL1 gene were PCR-amplified and directly sequenced using one PCR oligonucleotide as primer according to Hardelin et al., 1993.”
BackgroundMethodInfluentialSelf-citation
Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: Implications for the developmental anomalies of X chromosome-linked Kallmann syndrome
Hardelin, J., Julliard, A., Moniot, B., Soussi‐Yanicostas, N., Verney, C., Schwanzel‐Fukuda, M., Lièvre, C. A., & Petit, C. (1999) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199905)215:1 · Cited by 146
Self-citation
A Comparative Phenotypic Study of Kallmann Syndrome Patients Carrying Monoallelic and Biallelic Mutations in the Prokineticin 2 or Prokineticin Receptor 2 Genes
Sarfati, J., Guiochon‐Mantel, A., Rondard, P., Arnulf, I., García-Piñero, A., Wołczyński, S., Brailly‐Tabard, S., Bidet, M., Ramos‐Arroyo, M. A., Mathieu, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0843 · Cited by 147
Self-citation
Hypogonadotropic Hypogonadism in a Female Caused by an X-Linked Recessive Mutation in theDAX1Gene
Merke, D. P., Tajima, T., Baron, J., & Cutler, G. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401605 · Cited by 127
The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons
Cariboni, A. M., Pimpinelli, F., Colamarino, S. A., Zaninetti, R., Piccolella, M., Rumio, C., Piva, F., Rugarli, E. I., & Maggi, R. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh309 · Cited by 137
Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction
Cotton, L. M., O’Bryan, M. K., & Hinton, B. T. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0028 · Cited by 134
Genetic determinants of pubertal timing in the general population
Gajdos, Z. K. Z., Henderson, K. D., Hirschhorn, J. N., & Palmert, M. R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.038 · Cited by 121
“Mutations in Kallmann syndrome 1 (KAL-1) [42–44] and fibroblast growth factor receptor 1 (FGFR1) [45] have been implicated in the X-linked and autosomal dominant forms of the disease, respectively, but appear to account for only approximately 20% of patients with KS [46].”
Background
Contemporary issues in primary amenorrhea
Timmreck, L. S., & Reindollar, R. H. (2003) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(03)00027-5 · Cited by 120
Novel Fibroblast Growth Factor Receptor 1 Mutations in Patients with Congenital Hypogonadotropic Hypogonadism with and without Anosmia
Trarbach, E. B., Costa, E. M. F., Versiani, B. R., de Castro, M., Baptista, M. T. M., Garmes, H. M., Mendonca, B. B., & Latronico, A. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2793 · Cited by 107
Kallmann’s syndrome
Krams, M., Quinton, R., Ashburner, J., et al. (1999) · Neurology · doi:10.1212/wnl.52.4.816 · Cited by 106
Self-citation
The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome
Quaynor, S. D., Kim, H., Cappello, E. M., Williams, T., Chorich, L. P., Bick, D. P., Sherins, R. J., & Layman, L. C. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.046 · Cited by 108
“R257SX] (30, 31) NMD or protein truncation – – 24 IHH/M CHD7 [c.”
Background
Mechanisms of Disease: insights into X-linked and autosomal-dominant Kallmann syndrome
Tsai, P., & Gill, J. C. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0119 · Cited by 107
Inherited disorders of the gonadotropin hormones
Achermann, J. C., Weiss, J., Lee, E. J., & Jameson, J. L. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00474-9 · Cited by 101
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)
Bonomi, M., Vezzoli, V., Krausz, C. G., Guizzardi, F., Vezzani, S., Simoni, M., Bassi, I., Duminuco, P., Iorgi, N. D., Giavoli, C., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0065 · Cited by 103
Human GnRH Deficiency: A Unique Disease Model to Unravel the Ontogeny of GnRH Neurons
Balasubramanian, R., Dwyer, A. A., Seminara, S. B., Pitteloud, N., Kaiser, U. B., & Crowley, W. F. (2010) · Neuroendocrinology · doi:10.1159/000314193 · Cited by 104
Kallmann syndrome: towards molecular pathogenesis
Hardelin, J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00462-2 · Cited by 100
Self-citation
What controls the timing of puberty? An update on progress from genetic investigation
Gajdos, Z. K. Z., Hirschhorn, J. N., & Palmert, M. R. (2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328320253c · Cited by 95
X Chromosome-Linked Kallmann Syndrome: Clinical Heterogeneity in Three Siblings Carrying an Intragenic Deletion of theKAL-1Gene
Massin, N., Pécheux, C., Eloit, C., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021981 · Cited by 92
“Among the various anomalies associated with X-linked KS (9, 21), upper limb mirror movements (bimanual synkinesis) and unilateral renal aplasia are often encountered, because they affect over three fourths and one third of the patients, respectively (23, 24).”
BackgroundMethodSelf-citation
Unilateral renal aplasia in X‐linked Kallmann's syndrome
Kirk, J. M. W., Grant, D., BESSER, G. M., Shalet, S. M., Quinton, R., Smith, C. S., White, M., Edwards, O. M., & Bouloux, P. M. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04238.x · Cited by 91
Self-citation
Kallmann syndrome: fibroblast growth factor signaling insufficiency?
Dod�, C., & Hardelin, J. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0571-y · Cited by 92
“Most of the occasional anomalies, however, can be attributed to the mutated KAL genes [1, 2, 15], and they may be present in more than one genetic form of the disease, albeit with different prevalences (Table 3).”
Self-citation
Diversity in Fibroblast Growth Factor Receptor 1 Regulation: Learning from the Investigation of Kallmann Syndrome
Kim, S. ‐., Hu, Y., Cadman, S., & Bouloux, P. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01627.x · Cited by 87
Self-citation
C. elegans Kallmann syndrome protein KAL-1 interacts with syndecan and glypican to regulate neuronal cell migrations
Hudson, M. L., Kinnunen, T. K., Cinar, H. N., & Chisholm, A. D. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.02.036 · Cited by 80
“Recessive X-linked KS is caused by mutations in the KAL1 gene (Franco et al., 1991; Hardelin et al., 1992, 1993; Legouis et al., 1991), which encodes a secreted protein, anosmin-1.”
Clinical genetics of Kallmann syndrome
Dodé, C., & Hardelin, J. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2010.02.005 · Cited by 82
Self-citation
Genetics of hypogonadotropic hypogonadism
Seminara, S. B., Oliveira, L. M. B., Beranova, M., Hayes, F. J., & Crowley, W. F. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343776 · Cited by 81
The endocrine control of spermatogenesis
McLachlan, R. I. (2000) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0084 · Cited by 78
Complete Hypogonadotropic Hypogonadism Associated with a Novel Inactivating Mutation of the Gonadotropin-Releasing Hormone Receptor
Pralong, F. P., Gómez, F., Castillo, E., Cotecchia, S., Abuin, L., Aubert, M. L., Portmann, L., & Gaillard, R. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6042 · Cited by 90
Kallmann Syndrome
Rugarli, E. I. (1993) · JAMA · doi:10.1001/jama.270.22.2713 · Cited by 85
Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: Case Report
Sinisi, A. A., Asci, R., Bellastella, G., Maione, L., Esposito, D., Elefante, A., Bellis, A. D., Bellastella, A., & Iolascon, A. (2008) · Human Reproduction · doi:10.1093/humrep/den247 · Cited by 72
“The primers and programmes used for KAL1, FGFR1 and GnRHR coding exon analysis have been reported elsewhere (Hardelin et al., 1993; Sato et al., 2004; Antelli et al., 2006).”
Method
Isolated GnRH deficiency: A disease model serving as a unique prism into the systems biology of the GnRH neuronal network
Balasubramanian, R., & Crowley, W. F. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.012 · Cited by 69
Hypogonadotropic Hypogonadism
Layman, L. C. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.03.010 · Cited by 68
Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome
Xu, N., Kim, H., Bhagavath, B., Cho, S.-G., Lee, J. H., Ha, K., Meliciani, I., Wenzel, W., Podolsky, R. H., Chorich, L. P., et al. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.010 · Cited by 70
“Unilateral renal agenesis in this patient is likely related to this deleterious KAL1 mutation(43).”
Background
Functional MRI of Congenital Hyposmia: Brain Activation to Odors and Imagination of Odors and Tastes
Henkin, R. I., & Levy, L. M. (2002) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200201000-00008 · Cited by 68
Ear and kidney syndromes: molecular versus clinical approach.
Izzedine, H., Tankéré, F., Launay-Vacher, V., & Deray, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00390.x · Cited by 62
Kallmann’s syndrome, a neuronal migration defect
Cariboni, A., & Maggi, R. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5604-3 · Cited by 65
Disorders of sexual differentiation
Simpson, J. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991229)89:4 · Cited by 157
HYPOGONADOTROPIC HYPOGONADISM
Hayes, F. J., Seminara, S. B., & Crowley, W. F. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70039-6 · Cited by 62
Monogenic Disorders of Puberty
Kalantaridou, S., & Chrousos, G. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8668 · Cited by 65
Kallmann Syndrome and the Link between Olfactory and Reproductive Development
Rugarli, E. I. (1999) · The American Journal of Human Genetics · doi:10.1086/302600 · Cited by 55
A Review of Kallmann Syndrome: Genetics, Pathophysiology, and Clinical Management
Fechner, A. J., Fong, S., & McGovern, P. G. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3181641278 · Cited by 57
Clinical Manifestations of Impaired GnRH Neuron Development and Function
Kim, H., Bhagavath, B., & Layman, L. C. (2008) · Neurosignals · doi:10.1159/000111561 · Cited by 52
Genetic Analysis in Patients With Kallmann Syndrome: Coexistence of Mutations in Prokineticin Receptor 2 and KAL1
Canto, P., Munguía, P., Söderlund, D., Castro, J. J., & Méndez, J. P. (2008) · Journal of Andrology · doi:10.2164/jandrol.108.005314 · Cited by 54
A Recurrent Missense Mutation in the KAL Gene in Patients with X-Linked Kallmann’s Syndrome1
Maya‐Núñez, G., Zenteno, J. C., Ulloa‐Aguirre, A., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4817 · Cited by 52
The genetic basis of female reproductive disorders: Etiology and clinical testing
Layman, L. C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.016 · Cited by 48
“This has clinical relevance in affected patients as up to 50% of males with KAL1 mutations may have unilateral renal agenesis (Hardelin et al., 1993).”
Background
Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals
Layman, L. C., McDonough, P. G., Cohen, D., Maddox, M., Tho, S. P. T., & Reindollar, R. H. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01782-4 · Cited by 46
Molecular analysis of KAL-1, GnRH-R, NELF and EBF2 genes in a series of Kallmann syndrome and normosmic hypogonadotropic hypogonadism patients
Trarbach, E. B., Baptista, M. T. M., Garmes, H. M., & Hackel, C. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06103 · Cited by 46
“…to the flanking regions of the KAL-1 and GnRH-R exons, sizes of the amplified products and amplification conditions were as reported by Hardelin et al. (1993) and Beranova et al. (2001) respectively, and those for NELF (NM_015537) and EBF2 (NM_022659) are shown in Tables 2 and 3…”
BackgroundMethod
Biochemical dissection of Anosmin‐1 interaction with FGFR1 and components of the extracellular matrix
Murcia‐Belmonte, V., Esteban, P. F., García‐González, D., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07024.x · Cited by 41
Identification of Three Novel Mutations in the KAL1 Gene in Patients with Kallmann Syndrome
Söderlund, D., Canto, P., & Méndez, J. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8611 · Cited by 41
An ancient founder mutation in PROKR2 impairs human reproduction
Stefanija, M. A., Jeanpierre, M., Sykiotis, G. P., Young, J., Quinton, R., Abreu, A. P., Plummer, L., Au, M., Balasubramanian, R., Dwyer, A. A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds264 · Cited by 39
“PROKR2 mutations have been implicated in diverse oligogenic interactions, including mutations in other genes regulating GnRH neuron ontogeny such as PROK2, KAL1 and FGFR1 (11,12,15–17,34).”
BackgroundInfluential
Molecular modelling and experimental studies of mutation and cell-adhesion sites in the fibronectin type III and whey acidic protein domains of human anosmin-1
Robertson, A., MacColl, G., Nash, J. A. B., Boehm, M. K., Perkins, S. J., & Bouloux, P.-M. G. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570647 · Cited by 42
Self-citation
Contiguous gene syndrome due to deletion of the first three exons of the Kallmann gene and complete deletion of the steroid sulphatase gene
Maya‐Núñez, G., Cuevas‐Covarrubias, S. A., Zenteno, J. C., et al. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00406.x · Cited by 40
KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans
Bhagavath, B., Xu, N., Özata, M., et al. (2007) · Molecular Human Reproduction · doi:10.1093/molehr/gal108 · Cited by 39
“Initially, gene deletions were identified by Southern blot analysis (Bick et al., 1992), but a variety of point mutations were later characterized ( Hardelin et al., 1993 ).”
BackgroundMethodInfluential
Novel Insights into the Aetiology and Pathogenesis of Hypopituitarism
Dattani, M. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080493 · Cited by 39
Novel insights in FGFR1 regulation: lessons from Kallmann syndrome
Hu, Y., & Bouloux, P.-M. G. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.01.004 · Cited by 39
Self-citation
Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients
Sarfati, J., Fouveaut, C., Leroy, C., Jeanpierre, M., Hardelin, J., & Dodé, C. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0419 · Cited by 38
Self-citation
Perspective: The Importance of Genetic Defects in Humans in Elucidating the Complexities of the Hypothalamic-Pituitary-Gonadal Axis
Seminara, S. B., & Crowley, W. F. (2001) · Endocrinology · doi:10.1210/endo.142.6.8261 · Cited by 39
“Mutation analysis of patients with Xlinked Kallmann syndrome has revealed a spectrum of coding sequence abnormalities (40, 41).”
Background
Genetics of hypogonadotropic Hypogonadism—Human and mouse genes, inheritance, oligogenicity, and genetic counseling
Louden, E. D., Poch, A., Kim, H., Ben‐Mahmoud, A., Kim, S., & Layman, L. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111334 · Cited by 34
Renal dysgenesis and KAL1 gene defects in patients with sporadic Kallmann syndrome
Georgopoulos, N. A., Koika, V., Galli‐Τsinopoulou, A., Spiliotis, B. E., Adonakis, G. L., Keramida, M. K., Sgourou, A., Koufogiannis, K. D., Papachatzopoulou, A., Papavassiliou, A. G., et al. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.044 · Cited by 35
The Role of Prokineticins in the Pathogenesis of Hypogonadotropic Hypogonadism
Abreu, A. P., Kaiser, U. B., & Latronico, A. C. (2010) · Neuroendocrinology · doi:10.1159/000308880 · Cited by 36
Mutations in human gonadotropin genes and their physiologic significance in puberty and reproduction
Layman, L. C. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00431-2 · Cited by 31
Panel testing for the molecular genetic diagnosis of congenital hypogonadotropic hypogonadism – a clinical perspective
Al-Sayed, Y., & Howard, S. R. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01261-0 · Cited by 36
“Thus, genes such as ANOS1 (MIM 300836) [33, 34], CHD7 (MIM 608892) [7, 35], FGFR1 (MIM 136350) [36, 37], PROKR2 (MIM 607123) [38, 39], GNRHR (MIM 138850) [38, 40], TACR3 (MIM 162332) [41, 42] – indeed the majority of these 14 genes – have been repeatedly validated in international cohorts of patients with CHH and KS,…”
Background
Inherited disorders of the gonadotropin hormones
Jameson, J. L. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(96)03950-0 · Cited by 32
Olfactory System and Demyelination
García‐González, D., Murcia‐Belmonte, V., Clemente, D., & Castro, F. D. (2013) · The Anatomical Record · doi:10.1002/ar.22736 · Cited by 31
“…and intoxication, tumors and skull-cephalic traumas, and the paradigmatic case of genetic anosmia with hypogonadotrophic hypogonadism: Kallmann syndrome (KS; Maestre de San Juan, 1856; Kallmann et al., 1944; Shepherd, 1988; Hardelin et al., 1993; Victor and Ropper, 2001; Dod e and Hardelin, 2009).”
Background
Genetic and Environmental Correlates of Semen Quality
Storgaard, L., Bonde, J. P., Ernst, E., et al. (2006) · Epidemiology · doi:10.1097/01.ede.0000239730.47963.4e · Cited by 31
Renal abnormalities in patients with Kallmann syndrome
Zenteno, Méndez, Maya‐Núñez, et al. (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00027.x · Cited by 31
Two independent mutations in a family with neurofibromatosis type 1 (NF1)
Harder, A., Peters, H., Hoffmeyer, S., Buske, A., L�der, A., He�, D., Lehmann, R., N�rnberg, P., & Tinschert, S. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990305)83:1 · Cited by 34
Clinical Genetic Testing for Kallmann Syndrome
Layman, L. C. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1624 · Cited by 30
“The identification of renal agenesis in the RSV-negative group is perhapsunexpectedbecause it hasbeenacommonfinding in males with KAL1 mutations (12).”
Background
X-linked GnRH deficiency: Role of KAL-1 mutations in GnRH deficiency
Hu, Y., & Bouloux, P.-M. G. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.04.001 · Cited by 31
Self-citation
Expanding the genetic spectrum ofANOS1mutations in patients with congenital hypogonadotropic hypogonadism
Gonçalves, C. I., Fonseca, F., Borges, T., Cunha, F. M., & Lemos, M. C. (2016) · Human Reproduction · doi:10.1093/humrep/dew354 · Cited by 29
“Primer sequences were previously described (Hardelin et al., 1993), except for the forward primer for exon 1 (5’-TGGGAGGGAGGTCGGCGAGGAGGG-3’) and the reverse primer for exon 10 (5’-GTGAATGGATAAAAGAATGAGTGA-3’), which were designed using Primer 3 Plus (Untergasser et al., 2007).”
Method
The Molecular Basis of Human Hypogonadotropic Hypogonadism
Layman, L. C. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2912 · Cited by 26
A novel mutation of the KAL1 gene in monozygotic twins with Kallmann syndrome
Matsuo, T., Okamoto, S., Izumi, Y., et al. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430783 · Cited by 29
ERK1/2 signaling is essential for the chemoattraction exerted by human FGF2 and human anosmin‐1 on newborn rat and mouse OPCs via FGFR1
Murcia‐Belmonte, V., Medina-Rodriguez, E. M., Bribián, A., de Castro, F., & Esteban, P. F. (2013) · Glia · doi:10.1002/glia.22609 · Cited by 29
“The E514K and F517L substitutions in FnIII.3 produce a 2-fold and a 6-fold reduced binding affinity to FGFR1 in vitro (Hu et al., 2009), or impede the binding of FnIII.3 (Murcia-Belmonte et al., 2010), canceling the chemotropic effect of anosmin-1 on GN11 cells and NPs (Cariboni et al., 2004; Murcia-Belmonte et al., 2…”
BackgroundInfluential
Anosmin-1 immunoreactivity during embryogenesis in a primitive eutherian mammal
Dellovade, T., Hardelin, J., Soussi‐Yanicostas, N., Pfaff, D. W., Schwanzel‐Fukuda, M., & Petit, C. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00544-8 · Cited by 29
Self-citation
A Novel Nonsense Mutation of the KAL Gene in Two Brothers withKallmann Syndrome
Jansen, C., Hendriks-Stegeman, B. I., & Jansen, M. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023568 · Cited by 28
“The coding exons of the KAL gene were subsequently amplified by polymerase chain reaction (PCR). The sequences of the KAL primers, the sizes of the amplified products and the PCR conditions were previously described by Hardelin et al. [”
Method
Report of the Fourth International Workshop on Human X Chromosome Mapping 1993 (Part 1 of 4)
Schlessinger, D., Willard, H. F., & Mandel, J. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000133572 · Cited by 27

Authors: Hardelin, J.-P., Levilliers, J., Blanchard, S., Carel, J.-C., Leutenegger, M., Pinard-Bertelletto, J.-P., Bouloux, P., & Petit, C.
Affiliations: Centre National de la Recherche Scientifique (FR)
Hôpital Saint-Vincent-de-Paul (FR)
Royal Free London NHS Foundation Trust (GB)
Corresponding author: Petit, Christine
ORCID: Hardelin, Jean-Pierre
Carel, Jean-Claude
Petit, Christine
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 1993
Volume: 2
Issue: 4
Pages: 373-377
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/2.4.373
OpenAlex: W2153635587
Cited by: 203
References: 0
Citations by year: 2024: 1 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 2 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 10 · 2014: 4 · 2013: 10 · 2012: 5
FWCI: 7.49
Type: journal article
Language: en
Open access: closed
Locations: Human Molecular Genetics (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords: KAL1, hypogonadotropic hypogonadism, anosmia, mutational heterogeneity, point mutations, splice site mutation, renal aplasia, X-linked inheritance
MeSH terms: Amino Acid Sequence, Base Sequence, DNA, DNA Mutational Analysis, Humans, Genetic Linkage, Male, Molecular Sequence Data, Mutation, Oligodeoxyribonucleotides, X Chromosome, Point Mutation, Sequence Deletion, Kallmann Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks